^
Association details:
Biomarker:CNOT3 overexpression
Cancer:Lung Cancer
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression

Published date:
06/08/2019
Excerpt:
…found higher expression level of CNOT3 and lower expression level of receptor-interacting protein kinase 3 (RIPK3) in cisplatin-resistant A549 (A549/DDP) cells…
DOI:
10.1007/s10495-019-01550-y